Hook & thesis
Palantir just delivered another 'otherworldly' quarter and the market reaction was decisive: strong price action, improving breadth, and a meaningful reduction in visible short interest. With revenue growth accelerating, U.S. commercial strength showing up in the numbers and free cash flow now comfortably positive, the bears are running out of clean narratives to push the stock lower.
My tactical view: take a disciplined long position now, sized to your risk tolerance, and give the trade time to run through the next major catalysts. Entry at $175.00, stop at $160.00 and target at $220.00 over a mid-term horizon (45 trading days) balances the company's momentum with the reality of a premium valuation.
What Palantir does and why the market should care
Palantir builds and sells data integration and analytics platforms used by government and commercial customers for operational decision-making. Its software is deployed across defense, intelligence, healthcare, energy and finance — sectors where data consolidation and AI-driven workflows are high-value and sticky.
Why this matters now: Palantir has positioned itself as an AI-first software company for the enterprise and sovereign markets. That combination - product-led momentum in AI plus enduring government contracts - creates a high-margin, high-cash-flow business where continued adoption can sustain rapid revenue growth and justify premium multiples if execution holds.
Fresh evidence backing the thesis
- Revenue momentum: Management reported a 93% year-over-year revenue gain in the latest quarter, and U.S. commercial revenue grew 149% — clear evidence the company is scaling beyond its government roots into large enterprise AI deployments.
- Profitability and cash flow: The company is delivering very high margins; net income margin was reported at roughly 55% in the latest commentary, and free cash flow stands at about $3.36 billion. Return on assets is ~25.8% and return on equity ~30.9%, showing capital-light, high-return economics.
- Balance sheet and liquidity: Reported cash is $1.32 per share equivalent in the snapshot, and the enterprise value sits high given the market cap, but the business generates meaningful free cash flow that supports reinvestment and optionality.
- Technical and market structure: Price sits around $179.00 with strong momentum signals — the 10-day SMA is $159.80, the 9-day EMA is $163.97 and MACD is in bullish momentum. Short interest has been sizable but trending down (recent filings show ~68M shares short) and days-to-cover near ~2 days; elevated short-volume on rallies suggests squeezes are possible whenever momentum accelerates.
Valuation framing
On headline multiples the stock is expensive: the snapshot shows a price-to-earnings ratio north of 140 and price-to-book above 40. Price-to-sales and EV-to-sales metrics are similarly rich, implying the market prices in many years of high growth. That said, Palantir is showing the kind of revenue acceleration and margin profile that, if sustained, can justify premium multiples for a time—but there is very little margin for execution missteps.
In trade terms this means the upside is real but asymmetry is limited if growth decelerates. Our plan explicitly manages that risk by placing a stop below recent technical support and sizing a mid-term horizon to let catalysts play out.
Catalysts to drive the next leg
- Ongoing enterprise AI adoption: Continued momentum from commercial customers (already shown by 149% U.S. commercial growth) will be the clearest pathway to multiple expansion.
- Guidance and subsequent earnings prints: Management raised full-year guidance to roughly $8.154 billion — future beats vs that guide will keep momentum alive.
- Falling short interest / technical squeezes: The reduction in short interest and elevated short-volume during rallies can exacerbate upside on strong news days.
- New large enterprise or sovereign deployments: Announcements of multi-year commercial contracts or broader sovereign AI deals can materially extend revenue visibility and investor confidence.
Trade plan (actionable)
| Action | Price | Horizon |
|---|---|---|
| Entry | $175.00 | Mid term (45 trading days) — enough time for earnings follow-through, guidance updates and further commercial cadence to show up in results. |
| Stop loss | $160.00 | |
| Target | $220.00 |
Rationale: Entry at $175.00 gives a small buffer under the recent $179 price, allowing for a modest pullback to the rising short-term moving averages (10-day SMA $159.80, 9-day EMA $163.97) without stepping in at exhaustion. The stop at $160.00 sits just above the 10-day SMA, a logical technical invalidation point: a breach below that level would indicate momentum fading and justify exiting. Target $220.00 aligns with analyst optimism and leaves room for multiple expansion from here; it is below the higher bullish targets that have been suggested but still captures a meaningful move (and is below the 52-week high of $207.52 and the more bullish $245 targets some firms have proposed).
Sizing and risk management
Because the equity is richly valued, size this trade conservatively — no more than a small percentage of total portfolio risk capital unless you have conviction and can tolerate large valuation-driven drawdowns. Use the $160 stop to calculate position size so a full-stop loss hits your planned risk tolerance (e.g., 1-2% portfolio risk).
Risks and counterarguments
- Valuation risk: The stock trades at very high multiples (P/E >140, P/B >40). Any sign of slower growth or margin compression would likely trigger sharp multiple contraction, erasing gains quickly.
- Execution risk: Maintaining near-100% revenue growth is difficult at scale. If new customer uptake or large contract ramp schedules slip, the valuation becomes hard to defend.
- Concentration and customer/campaign risk: A meaningful portion of revenue still comes from government and large enterprise customers; contract timing, renewals and budget cycles can cause lumpiness.
- Macro/market risk: In a risk-off environment, high-flying growth names tend to underperform first. Even with good fundamentals, Palantir is vulnerable to broad market de-risking.
- Bear case / counterargument: The clearest counterargument is that the market already prices multiple years of near-double-digit revenue growth; that leaves little room for error. If the next prints show sequential deceleration or if guidance disappoints relative to the newly raised $8.154B full-year target, the stock could fall sharply. Institutional selling into rallies (noted in recent flows) could also add pressure.
What would change my mind
I would abandon the long bias if any of the following occur:
- Q3 revenue growth drops materially below the current growth rate trajectory (substantial deceleration vs the recent 93% year-over-year print).
- Margins contract meaningfully or free cash flow suddenly weakens on changing customer economics.
- Price breaks and holds below $160 on strong volume — that would indicate momentum failure and likely open a wider drawdown period.
Conclusion
Palantir's latest results and subsequent price action have turned an academic debate about valuation into a tactical setup. Momentum is real, cash flow is real and the technical plumbing favors continuation. That doesn't erase the lofty multiples, but it does create a tradeable asymmetry: controlled entry at $175, stop at $160 and a realistic mid-term target of $220 gives a disciplined path to participate without overexposing to valuation risk.
If you trade it, size thoughtfully, monitor upcoming reports and be prepared to tighten if the market shows signs of re-pricing the company's growth assumptions.